Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...] …
Blog Posts
Breaking News
Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate
French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...] …
News Alert
Proposition 34: Voters Narrowly Back Controversial California 340B ‘Revenge’ Ballot Measure
California voters have narrowly endorsed Proposition 34, a controversial Nov. 5 ballot measure that would require at least one major [...] …
President-elect Donald Trump this week selected Mehmet Oz as his pick for Centers for Medicare & Medicaid Services (CMS) administrator, [...] …
Three additional House Democrats—including a high-profile New York congresswoman—have signed on as co-sponsors to legislation that would bar drugmaker restrictions [...] …
SPONSORED CONTENT
As a pharmacist and executive pharmacy leader, I nodded in affirmation when reading McKinsey & Company describe pharmacy services as a critical source of value for health centers and hospital systems,
…
Katheryne Richardson, a former senior global pricing strategist at Bristol-Myers Squibb (BMS) and longtime vice president of Apexus, this week [...] …
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
SPONSORED CONTENT
The 340B program is designed to help healthcare providers serving vulnerable populations stretch scarce resources as far as possible. In the face of increasing manufacturer restrictions, it is crucial for safety-net providers to explore various strategies to maintain financial sustainability. One of the
…